JULIE MACCLUSKEY: Open Payments
NPI 1437162351 · DURANGO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 3 payments from 3 companies in 2025. Trend: 2023 $350 · 2024 $156 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $109 |
| Kite Pharma, Inc. | 1 | $24 |
| Celgene Corporation | 1 | $20 |
Products named: SARCLISA, Yescarta, REBLOZYL.
Industry payments across CO — which companies pay providers there.
